Literature DB >> 18333040

Three cases of small hepatocellular carcinoma presenting as obstructive jaundice.

N Ise1, H Andoh, T Sato, O Yasui, T Kurokawa, H Kotanagi.   

Abstract

BACKGROUND: Despite improved diagnostic tools, it is often difficult to make a correct diagnosis of small hepatocellular carcinoma (HCC) in patients with obstructive jaundice. CASE OUTLINES: Three cases of small HCC (<2 cm diameter) presenting as obstructive jaundice are reported. All tumours were initially diagnosed as hilar cholangiocarcinoma based on ultrasonography, computed tomography, cholangiography and angiography. Because of insufficient hepatic function, none of the patients underwent hepatic resection. One patient died 8 months after first admission to our hospital, another died of disseminated intravascular coagulation I month after admission, and the third was treated with hepatic arterial infusion chemotherapy and survived >36 months.
CONCLUSION: It is important to consider HCC in the diagnosis of obstructive jaundice in patients who are predisposed to HCC because of liver cirrhosis and/or chronic viral hepatitis, and have elevated serum alpha-fetoprotein.

Entities:  

Year:  2004        PMID: 18333040      PMCID: PMC2020647          DOI: 10.1080/13651820310017129

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  15 in total

1.  Multidisciplinary approach to palliation of obstructive jaundice caused by a central hepatocellular carcinoma.

Authors:  J M Läuffer; G Mai; D Berchtold; C G Curti; J Triller; H U Baer
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

2.  Icteric type hepatoma.

Authors:  T Y Lin; K M Chen; Y R Chen; W S Lin; T H Wang; J L Sung
Journal:  Med Chir Dig       Date:  1975

3.  Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management.

Authors:  M Shiomi; J Kamiya; M Nagino; K Uesaka; T Sano; N Hayakawa; M Kanai; H Yamamoto; Y Nimura
Journal:  Surgery       Date:  2001-06       Impact factor: 3.982

4.  A logical approach to hepatocellular carcinoma presenting with jaundice.

Authors:  W Lau; K Leung; T W Leung; C T Liew; M S Chan; S C Yu; A K Li
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

5.  Icteric type hepatocellular carcinoma: revisited 20 years later.

Authors:  G T Huang; J C Sheu; H S Lee; M Y Lai; T H Wang; D S Chen
Journal:  J Gastroenterol       Date:  1998-02       Impact factor: 7.527

6.  Hepatic resection for icteric type hepatocellular carcinoma.

Authors:  M Shimada; K Takenaka; H Hasegawa; K Shirabe; T Gion; T Kano; K Sugimachi
Journal:  Hepatogastroenterology       Date:  1997 Sep-Oct

7.  Management of hepatocellular carcinoma presenting as obstructive jaundice.

Authors:  W Y Lau; J W Leung; A K Li
Journal:  Am J Surg       Date:  1990-09       Impact factor: 2.565

8.  Surgery of icteric-type hepatoma after biliary drainage and transcatheter arterial embolization.

Authors:  K Tada; K Kubota; K Sano; T Noie; T Kosuge; T Takayama; M Makuuchi
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

9.  Cholangiography of icteric type hepatoma.

Authors:  C S Wu; S S Wu; P C Chen; C T Chiu; S M Lin; Y Y Jan; C F Hung
Journal:  Am J Gastroenterol       Date:  1994-05       Impact factor: 10.864

10.  Cholangiographic features in the diagnosis and management of obstructive icteric type hepatocellular carcinoma.

Authors:  W Y Lau; C K Leow; K L Leung; T W Leung; M Chan; S C Yu
Journal:  HPB Surg       Date:  2000
View more
  2 in total

1.  A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus.

Authors:  Anon Chotirosniramit; Akkaphod Liwattanakun; Worakitti Lapisatepun; Wasana Ko-Iam; Trichak Sandhu; Sunhawit Junrungsee
Journal:  J Hepatocell Carcinoma       Date:  2017-03-07

2.  Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge.

Authors:  Xiaoqi Zhou; Jifei Wang; Mimi Tang; Mengqi Huang; Ling Xu; Zhenpeng Peng; Zi-Ping Li; Shi-Ting Feng
Journal:  BMC Cancer       Date:  2020-01-22       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.